New Data on Biogen's Alprolix - Analyst Blog Biogen Idec ( BIIB ) and Swedish Orphan Biovitrum AB recently presented new data on their hemophilia B candidate, Alprolix, at the XXIV International Society on Thrombosis and Haemostasis (ISTH)
July 3, 2013 - Nasdaq